æz ɪmplˈaɪd baɪ ðə sˈʌfɪks zjˈuːmæb, ɪɾ ɪz ɐ ɹˌiːkˈɑːmbɪnənt hjˈuːmənˌaɪzd mˈɑːnoʊklˌɑːnəl ˈæntɪbˌɑːdi ɐdmˈɪnɪstɚd wˈʌns wˈiːkli baɪ sˌʌbkjuːtˈeɪniəs ɪndʒˈɛkʃən.
As implied by the suffix -zumab, it is a recombinant humanized monoclonal antibody  administered once weekly by subcutaneous injection.